Page last updated: 2024-08-23

mifepristone and Chronic Lung Injury

mifepristone has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dye, JA; Henriquez, AR; Kodavanti, UP; Ledbetter, AD; Mauge-Lewis, K; McGee, MA; Miller, CN; Richards, JE; Schladweiler, MC; Snow, SJ1
Cai, QQ; Hong, GL; Jiang, XZ; Li, MF; Lu, ZQ; Qiu, QM; Tan, JP; Wu, B; Zhao, GJ1

Other Studies

2 other study(ies) available for mifepristone and Chronic Lung Injury

ArticleYear
Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation.
    Toxicology and applied pharmacology, 2018, 01-15, Volume: 339

    Topics: Adrenergic beta-Antagonists; Animals; Bronchoalveolar Lavage Fluid; Hormone Antagonists; Inflammation; Inflammation Mediators; Lung Injury; Male; Mifepristone; Ozone; Rats; Rats, Inbred WKY; Receptors, Adrenergic; Receptors, Glucocorticoid

2018
Mifepristone-inducible recombinant adenovirus attenuates paraquat-induced lung injury in rats.
    Human & experimental toxicology, 2015, Volume: 34, Issue:1

    Topics: Adenoviridae; Animals; Bronchoalveolar Lavage Fluid; Catalase; Cytokines; Glutathione; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Herbicides; Lung; Lung Injury; Male; Mifepristone; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Paraquat; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor RelA

2015